Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusion for Treatment of Chronic Neuropathic Pain in Traumatic Brachial Plexus Injuries
NCT04933149Phase 4Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Dec 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in neuropathic pain, sponsored by Mayo Clinic. Started Dec 2021; status: enrolling by invitation.
02
Drugs
ketamine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04933149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04933149.